首页 > 最新文献

Wits journal of clinical medicine最新文献

英文 中文
Walls of Silence 沉默之墙
Pub Date : 2021-01-01 DOI: 10.18772/26180197.2021.v3n3a9
G. Kantor
{"title":"Walls of Silence","authors":"G. Kantor","doi":"10.18772/26180197.2021.v3n3a9","DOIUrl":"https://doi.org/10.18772/26180197.2021.v3n3a9","url":null,"abstract":"","PeriodicalId":75326,"journal":{"name":"Wits journal of clinical medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81232561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
All you need to know about COVID-19 and Vaccines (National Institute for Communicable Diseases) 所有你需要知道的关于COVID-19和疫苗(国家传染病研究所)
Pub Date : 2021-01-01 DOI: 10.18772/26180197.2021.v3n1a16
{"title":"All you need to know about COVID-19 and Vaccines (National Institute for Communicable Diseases)","authors":"","doi":"10.18772/26180197.2021.v3n1a16","DOIUrl":"https://doi.org/10.18772/26180197.2021.v3n1a16","url":null,"abstract":"","PeriodicalId":75326,"journal":{"name":"Wits journal of clinical medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90600510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronavirus Disease 2019 (COVID-19) and Psychiatric Sequelae in South Africa: Anxiety and Beyond. 南非 2019 年冠状病毒病(COVID-19)与精神后遗症:焦虑及其他。
Pub Date : 2020-07-01 DOI: 10.18772/26180197.2020.v2n2a2
Ugasvaree Subramaney, Andrew Wooyoung Kim, Indhrin Chetty, Shren Chetty, Preethi Jayrajh, Mallorie Govender, Pralene Maharaj, EungSok Pak

Background: The 2019 coronavirus (COVID-19) pandemic has brought unprecedented challenges to the health sector nationwide and internationally. Across all disciplines, unique and novel modes of presentation with substantial morbidity and mortality are being encountered, and growing evidence suggests that psychiatric comorbidity is likely among COVID-19 patients.

Objective: This article aims to broaden the current discussion on the psychiatric sequalae of COVID-19, which has largely focused on anxiety, and examine the recently documented psychiatric sequelae of COVID-19 infection, the secondary effects of the pandemic on public mental health, and future psychiatric conditions that may arise due to COVID-19.

Methods: We conducted an in-depth review of the current global psychiatric literature and describe the wide range of psychopathological presentations reported among past COVID-19 patients worldwide and those that are expected to emerge.

Results: Current discussions in the psychiatric literature on COVID-19 report anxiety and anxiety disorders as a predominant set of clinical presentations during the pandemic. The impacts of direct COVID-19 infection, associated psychopathological sequelae, and drastic lifestyle changes due to the COVID-19 pandemic in South Africa, are associated with a broad range of psychopathologies and other neuropsychiatric presentations. Pre-existing societal conditions and burdens on the health system in South Africa prompt healthcare providers and public health planners to accordingly prepare for the expected rise in new psychiatric presentations.

Conclusion: Greater awareness of the various psychiatric conditions attributed to COVID-19 infection may allow for earlier screening, more effective treatment, and greater positive health outcomes and better prepare health systems to address the growing pandemic in South Africa.

背景:2019 年冠状病毒(COVID-19)大流行给全国和国际卫生部门带来了前所未有的挑战。在所有学科中,都出现了发病率和死亡率极高的独特和新颖的发病模式,越来越多的证据表明,COVID-19 患者很可能合并精神疾病:本文旨在拓宽目前关于 COVID-19 精神病后遗症的讨论范围(目前的讨论主要集中在焦虑方面),并研究最近记录在案的 COVID-19 感染的精神后遗症、大流行病对公众心理健康的继发影响以及未来可能因 COVID-19 而出现的精神疾病:我们对当前全球精神病学文献进行了深入综述,并描述了全球过去的 COVID-19 患者中报告的各种精神病理学表现以及预计会出现的精神病理学表现:结果:目前有关 COVID-19 的精神病学文献报告称,焦虑和焦虑症是大流行期间的主要临床表现。在南非,COVID-19 的直接感染、相关的精神病理后遗症以及 COVID-19 大流行所导致的生活方式的急剧改变,都与广泛的精神病理和其他神经精神症状有关。南非原有的社会状况和医疗系统的负担促使医疗服务提供者和公共卫生规划者做好相应的准备,以应对新的精神病发病率的预期增长:结论:提高对 COVID-19 感染导致的各种精神疾病的认识,可使筛查更早、治疗更有效、健康结果更积极,并使医疗系统做好更充分的准备,以应对南非日益严重的大流行病。
{"title":"Coronavirus Disease 2019 (COVID-19) and Psychiatric Sequelae in South Africa: Anxiety and Beyond.","authors":"Ugasvaree Subramaney, Andrew Wooyoung Kim, Indhrin Chetty, Shren Chetty, Preethi Jayrajh, Mallorie Govender, Pralene Maharaj, EungSok Pak","doi":"10.18772/26180197.2020.v2n2a2","DOIUrl":"10.18772/26180197.2020.v2n2a2","url":null,"abstract":"<p><strong>Background: </strong>The 2019 coronavirus (COVID-19) pandemic has brought unprecedented challenges to the health sector nationwide and internationally. Across all disciplines, unique and novel modes of presentation with substantial morbidity and mortality are being encountered, and growing evidence suggests that psychiatric comorbidity is likely among COVID-19 patients.</p><p><strong>Objective: </strong>This article aims to broaden the current discussion on the psychiatric sequalae of COVID-19, which has largely focused on anxiety, and examine the recently documented psychiatric sequelae of COVID-19 infection, the secondary effects of the pandemic on public mental health, and future psychiatric conditions that may arise due to COVID-19.</p><p><strong>Methods: </strong>We conducted an in-depth review of the current global psychiatric literature and describe the wide range of psychopathological presentations reported among past COVID-19 patients worldwide and those that are expected to emerge.</p><p><strong>Results: </strong>Current discussions in the psychiatric literature on COVID-19 report anxiety and anxiety disorders as a predominant set of clinical presentations during the pandemic. The impacts of direct COVID-19 infection, associated psychopathological sequelae, and drastic lifestyle changes due to the COVID-19 pandemic in South Africa, are associated with a broad range of psychopathologies and other neuropsychiatric presentations. Pre-existing societal conditions and burdens on the health system in South Africa prompt healthcare providers and public health planners to accordingly prepare for the expected rise in new psychiatric presentations.</p><p><strong>Conclusion: </strong>Greater awareness of the various psychiatric conditions attributed to COVID-19 infection may allow for earlier screening, more effective treatment, and greater positive health outcomes and better prepare health systems to address the growing pandemic in South Africa.</p>","PeriodicalId":75326,"journal":{"name":"Wits journal of clinical medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162198/pdf/nihms-1661700.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9153785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronavirus Disease 2019 (COVID-19) Resources 2019冠状病毒病(COVID-19)资源
Pub Date : 2020-04-01 DOI: 10.18772/26180197.2020.v2nsiamr
{"title":"Coronavirus Disease 2019 (COVID-19) Resources","authors":"","doi":"10.18772/26180197.2020.v2nsiamr","DOIUrl":"https://doi.org/10.18772/26180197.2020.v2nsiamr","url":null,"abstract":"","PeriodicalId":75326,"journal":{"name":"Wits journal of clinical medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74544053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Should ACE Inhibitors and Angiotensin Receptor Blockers Be Withdrawn in the Current Setting of COVID-19 Infection? 在COVID-19感染的当前情况下,ACE抑制剂和血管紧张素受体阻滞剂是否应该停用?
Pub Date : 2020-04-01 DOI: 10.18772/26180197.2020.v2nSIa4
P. Manga
At the end of February 2020 and early March 2020, the British Medical Journal and the Lancet Respiratory Medicine Journal, respectively, published reports which hypothesized that patients with cardiac diseases, hypertension or diabetes, who are treated with angiotensin converting enzyme ACE inhibitors or angiotensin receptor blockers (ARBs), were more susceptible to COVID-19 (SARS-CoV-2) infection.(1,2) In one of the largest published series in Wuhan, China, cardiovascular comorbidities such as hypertension, coronary artery disease and diabetes have reported to be common in patients admitted to hospital with COVID-19 infection.(3) In this study of 1099 patients with confirmed COVID-19 infection and of 173 who were classified as having severe diseases, hypertension was reported to be prevalent in 23.7%, diabetes mellitus in 16.2% and coronary artery disease in 5.8%.(3) Although these conditions are often treated in hospitals with ACE inhibitors and ARBs, the effects of these treatment strategies on mortality were not assessed in this study.
2020年2月底和3月初,《英国医学杂志》和《柳叶刀呼吸医学杂志》分别发表报告,假设接受血管紧张素转换酶ACE抑制剂或血管紧张素受体阻阻剂(ARBs)治疗的心脏病、高血压或糖尿病患者更容易感染COVID-19 (SARS-CoV-2)。(1,2)在中国武汉发表的一项最大的系列研究中,高血压、冠状动脉疾病、糖尿病等心血管合并症在COVID-19感染住院患者中较为常见。(3)本研究1099例确诊COVID-19感染患者和173例重症患者中,高血压患病率为23.7%;糖尿病占16.2%,冠心病占5.8%。(3)虽然这些疾病在医院经常使用ACE抑制剂和arb治疗,但本研究未评估这些治疗策略对死亡率的影响。
{"title":"Should ACE Inhibitors and Angiotensin Receptor Blockers Be Withdrawn in the Current Setting of COVID-19 Infection?","authors":"P. Manga","doi":"10.18772/26180197.2020.v2nSIa4","DOIUrl":"https://doi.org/10.18772/26180197.2020.v2nSIa4","url":null,"abstract":"At the end of February 2020 and early March 2020, the British Medical Journal and the Lancet Respiratory Medicine Journal, respectively, published reports which hypothesized that patients with cardiac diseases, hypertension or diabetes, who are treated with angiotensin converting enzyme ACE inhibitors or angiotensin receptor blockers (ARBs), were more susceptible to COVID-19 (SARS-CoV-2) infection.(1,2) In one of the largest published series in Wuhan, China, cardiovascular comorbidities such as hypertension, coronary artery disease and diabetes have reported to be common in patients admitted to hospital with COVID-19 infection.(3) In this study of 1099 patients with confirmed COVID-19 infection and of 173 who were classified as having severe diseases, hypertension was reported to be prevalent in 23.7%, diabetes mellitus in 16.2% and coronary artery disease in 5.8%.(3) Although these conditions are often treated in hospitals with ACE inhibitors and ARBs, the effects of these treatment strategies on mortality were not assessed in this study.","PeriodicalId":75326,"journal":{"name":"Wits journal of clinical medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77357117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Clinical Ethical Challenges in the Covid-19 Crisis in South Africa 南非Covid-19危机中的临床伦理挑战
Pub Date : 2020-04-01 DOI: 10.18772/26180197.2020.v2nsia5
K. Behrens
In a recent paper, the USA-based Hastings Center, which addresses social and ethical issues in health care, science and technology, observes that in public health emergencies a shift needs to take place away from the ethical norms of standard clinical practice, which is patient-centred and responsive to individual patient preferences, towards public health ethics, which is concerned with safeguarding the health of the population by means of the best use of resources. This can entail limiting individual rights and choices.(1) They assert that “public health emergencies may feature tragically limited resources that are insufficient to save lives that under normal conditions could be saved”.(1) This necessitates decisions about how to allocate limited resources: “In a public health emergency featuring severe respiratory illness, triage decisions may have to be made about level of care ...; initiation of life-sustaining treatment ...; withdrawal of life-sustaining treatment; and referral to palliative ... care if life-sustaining treatment will not be initiated or is withdrawn”.(1) This is equally true in the South African context. However, clinicians here may be more accustomed to working with limited resources and rationing decisions, and the tension between the patient-centred and public health orientations might not be as unfamiliar or stark for them. However, this does not change the fact that triage decisions take their toll on health-care workers, emotionally. The Hastings Center asserts that one important way in which this emotional distress can be alleviated is by ensuring that there are clear rules in place for public health emergencies, for instance, “triage protocols ... help first responders to swiftly prioritize patients for different levels of care based on their needs and their ability to respond to treatment given resource constraints”.(1) Unclear rules or rules that cause patient distress can lead to moral distress in caregivers, especially in situations in which protocols require the withholding or withdrawing of treatment against the wishes of patients or their families. Thus, there is a critical need and an ethical obligation for ethics guidelines for decision-making about treatment allocation to be in place before the pandemic reaches the level where tragic choices need to be made. The question now is, what would an ethically sound policy for rationing in a health emergency look like? In a recently published paper entitled “Fair allocation of scarce medical resources in the time of Covid-19”, Emanuel et al. write that the literature on resource allocation in pandemics emphasizes four main values that should inform policies: “Maximizing the benefits produced by scarce resources, treating people equally, promoting and rewarding instrumental value and giving priority to the worst off ”.(2) They go on to make six recommendations derived from these four principles. It is not possible to discuss these in any detail here, and only the f
在最近的一篇论文中,美国的黑斯廷斯中心(该中心处理保健、科学和技术方面的社会和伦理问题)指出,在公共卫生紧急情况中,需要从以病人为中心并对病人个人喜好作出反应的标准临床实践的伦理规范转向公共卫生伦理,这涉及通过最佳利用资源来保障人口健康。这可能会限制个人的权利和选择。(1)他们断言,"突发公共卫生事件的可悲特点是,资源有限,不足以挽救在正常情况下可以挽救的生命"。(1)这就需要决定如何分配有限的资源:"在突发公共卫生事件中,出现严重呼吸道疾病时,可能必须就护理水平作出分类决定。;开始生命维持治疗…;停止维持生命的治疗;转诊到姑息治疗…(1)在南非的情况下同样如此。然而,这里的临床医生可能更习惯于在有限的资源和配给决策下工作,以患者为中心和公共卫生取向之间的紧张关系对他们来说可能并不陌生或明显。然而,这并不能改变这样一个事实,即分诊决定在情感上给卫生保健工作者造成了伤害。黑斯廷斯中心断言,缓解这种情绪困扰的一个重要方法是确保为突发公共卫生事件制定明确的规则,例如,“分诊协议……(1)不明确的规则或导致患者痛苦的规则可能会导致护理人员的道德痛苦,特别是在协议要求在违背患者或其家属意愿的情况下暂停或撤回治疗的情况下。因此,在疫情达到需要作出悲剧性选择的程度之前,制定有关治疗分配决策的道德准则是一种迫切需要和道德义务。现在的问题是,在卫生紧急情况下,合乎道德的定量配给政策是什么样的?伊曼纽尔等人在最近发表的一篇题为《Covid-19时期稀缺医疗资源的公平分配》的论文中写道,关于大流行病中资源分配的文献强调了四个主要的价值观,这些价值观应该为政策提供信息:“最大限度地利用稀缺资源产生的利益,平等对待人,促进和奖励工具价值,优先考虑最贫困的人”。(2)他们继续根据这四个原则提出了六条建议。这里不可能详细讨论这些,下面只简要讨论最相关的四项建议。(2)他们的第一个建议是,面对大流行时最重要的价值是最大限度地利用稀缺资源。他们断言,"有限资源的优先重点应放在拯救最多生命和最大限度地延长个人治疗后的寿命上"。(2)鉴于时间和信息不足,他们继续声称,“有理由优先考虑最大限度地提高患者在合理预期寿命下的存活率,并将最大限度地提高寿命长度作为次要目标”。(2)最近的一些出版物广泛同意这一立场。(3-6)Emanuel等人承认,有许多可能的方法可以在挽救更多生命和挽救更多生命年之间寻求平衡。但无论选择何种平衡手段,都应始终如一地适用。(2)这一建议在南非和其他任何地方都同样适用。在我们的背景下,它带来的最大挑战与我们医疗体系中现有的不平等有关,私营部门的资源要多得多
{"title":"Clinical Ethical Challenges in the Covid-19 Crisis in South Africa","authors":"K. Behrens","doi":"10.18772/26180197.2020.v2nsia5","DOIUrl":"https://doi.org/10.18772/26180197.2020.v2nsia5","url":null,"abstract":"In a recent paper, the USA-based Hastings Center, which addresses social and ethical issues in health care, science and technology, observes that in public health emergencies a shift needs to take place away from the ethical norms of standard clinical practice, which is patient-centred and responsive to individual patient preferences, towards public health ethics, which is concerned with safeguarding the health of the population by means of the best use of resources. This can entail limiting individual rights and choices.(1) They assert that “public health emergencies may feature tragically limited resources that are insufficient to save lives that under normal conditions could be saved”.(1) This necessitates decisions about how to allocate limited resources: “In a public health emergency featuring severe respiratory illness, triage decisions may have to be made about level of care ...; initiation of life-sustaining treatment ...; withdrawal of life-sustaining treatment; and referral to palliative ... care if life-sustaining treatment will not be initiated or is withdrawn”.(1) This is equally true in the South African context. However, clinicians here may be more accustomed to working with limited resources and rationing decisions, and the tension between the patient-centred and public health orientations might not be as unfamiliar or stark for them. However, this does not change the fact that triage decisions take their toll on health-care workers, emotionally. The Hastings Center asserts that one important way in which this emotional distress can be alleviated is by ensuring that there are clear rules in place for public health emergencies, for instance, “triage protocols ... help first responders to swiftly prioritize patients for different levels of care based on their needs and their ability to respond to treatment given resource constraints”.(1) Unclear rules or rules that cause patient distress can lead to moral distress in caregivers, especially in situations in which protocols require the withholding or withdrawing of treatment against the wishes of patients or their families. Thus, there is a critical need and an ethical obligation for ethics guidelines for decision-making about treatment allocation to be in place before the pandemic reaches the level where tragic choices need to be made. The question now is, what would an ethically sound policy for rationing in a health emergency look like? In a recently published paper entitled “Fair allocation of scarce medical resources in the time of Covid-19”, Emanuel et al. write that the literature on resource allocation in pandemics emphasizes four main values that should inform policies: “Maximizing the benefits produced by scarce resources, treating people equally, promoting and rewarding instrumental value and giving priority to the worst off ”.(2) They go on to make six recommendations derived from these four principles. It is not possible to discuss these in any detail here, and only the f","PeriodicalId":75326,"journal":{"name":"Wits journal of clinical medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75767616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Patient guide - COVID 19 患者指南- COVID - 19
Pub Date : 2020-04-01 DOI: 10.18772/26180197.2020.v2nsiapg
{"title":"Patient guide - COVID 19","authors":"","doi":"10.18772/26180197.2020.v2nsiapg","DOIUrl":"https://doi.org/10.18772/26180197.2020.v2nsiapg","url":null,"abstract":"","PeriodicalId":75326,"journal":{"name":"Wits journal of clinical medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81179758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case Study: A Patient with Asthma, Covid-19 Pneumonia and Cytokine Release Syndrome Treated with Corticosteroids and Tocilizumab 病例研究:1例哮喘、Covid-19肺炎和细胞因子释放综合征患者接受皮质类固醇和托珠单抗治疗
Pub Date : 2020-04-01 DOI: 10.18772/26180197.2020.v2nSIa9
G. Schleicher, W. Lowman, G. Richards
Severe acute respiratory syndrome coronavirus-2 (SARSCoV-2) is the novel coronavirus first detected in Wuhan, China, that causes coronavirus disease 2019 (Covid-19) and pneumonia. Covid-19 pneumonia is defined by a positive result for SARS-CoV-2 on a reverse-transcriptase– polymerase-chain-reaction (RT-PCR) assay of a specimen collected from the upper or lower respiratory tract together with radiological features of pneumonia and clinical features of hypoxaemia and dyspnoea. Although more than 80% of patients with Covid-19 infection have mild disease and make a full recovery, a significant proportion of patients progress to pneumonia, and about half of these cases will develop severe acute respiratory syndrome (ARDS). Initial reports from China suggested that age >65 years and medical comorbidities are risk factors for poor outcomes.(1) The need for ICU admission and mechanical ventilation once ARDS develops is associated with a high mortality, ranging from 39% to 72%.(2,3) Current guidelines recommend that corticosteroids or immunosuppressive therapy should not be used in patients with Covid-19 pneumonia unless there are other indications, such as shock, asthma or exacerbation of chronic obstructive pulmonary disease.(4) However, the role of systemic corticosteroids is currently being re-evaluated in mechanically ventilated adults with ARDS, with some guidelines now suggesting their use.(5) We describe a case of a patient with Covid-19 infection, progressive pneumonia, development of a hyperinflammatory state and cytokine release syndrome (CRS) who was successfully treated with steroids and tocilizumab. CASE REPORT
严重急性呼吸综合征冠状病毒-2 (SARSCoV-2)是在中国武汉首次发现的新型冠状病毒,可引起2019冠状病毒病(Covid-19)和肺炎。Covid-19肺炎的定义是对从上呼吸道或下呼吸道采集的标本进行逆转录酶-聚合酶链反应(RT-PCR)检测,结果为SARS-CoV-2阳性,同时伴有肺炎的放射学特征和低氧血症和呼吸困难的临床特征。虽然超过80%的Covid-19感染患者病情轻微并完全康复,但很大比例的患者会发展为肺炎,其中约一半的病例会发展为严重急性呼吸综合征(ARDS)。来自中国的初步报告显示,年龄>65岁和医疗合并症是不良预后的危险因素。(1)一旦发生ARDS,需要ICU住院和机械通气与高死亡率相关,死亡率在39%至72%之间。(2,3)目前的指南建议,除非有其他适应症,如休克,否则Covid-19肺炎患者不应使用皮质类固醇或免疫抑制治疗。(4)然而,目前正在重新评估全身性皮质类固醇在机械通气的ARDS成人患者中的作用,一些指南现在建议使用它们。(5)我们描述了一例患有Covid-19感染,进行性肺炎,发展为高炎症状态和细胞因子释放综合征(CRS)的患者,他成功地使用类固醇和托珠单抗治疗。病例报告
{"title":"Case Study: A Patient with Asthma, Covid-19 Pneumonia and Cytokine Release Syndrome Treated with Corticosteroids and Tocilizumab","authors":"G. Schleicher, W. Lowman, G. Richards","doi":"10.18772/26180197.2020.v2nSIa9","DOIUrl":"https://doi.org/10.18772/26180197.2020.v2nSIa9","url":null,"abstract":"Severe acute respiratory syndrome coronavirus-2 (SARSCoV-2) is the novel coronavirus first detected in Wuhan, China, that causes coronavirus disease 2019 (Covid-19) and pneumonia. Covid-19 pneumonia is defined by a positive result for SARS-CoV-2 on a reverse-transcriptase– polymerase-chain-reaction (RT-PCR) assay of a specimen collected from the upper or lower respiratory tract together with radiological features of pneumonia and clinical features of hypoxaemia and dyspnoea. Although more than 80% of patients with Covid-19 infection have mild disease and make a full recovery, a significant proportion of patients progress to pneumonia, and about half of these cases will develop severe acute respiratory syndrome (ARDS). Initial reports from China suggested that age >65 years and medical comorbidities are risk factors for poor outcomes.(1) The need for ICU admission and mechanical ventilation once ARDS develops is associated with a high mortality, ranging from 39% to 72%.(2,3) Current guidelines recommend that corticosteroids or immunosuppressive therapy should not be used in patients with Covid-19 pneumonia unless there are other indications, such as shock, asthma or exacerbation of chronic obstructive pulmonary disease.(4) However, the role of systemic corticosteroids is currently being re-evaluated in mechanically ventilated adults with ARDS, with some guidelines now suggesting their use.(5) We describe a case of a patient with Covid-19 infection, progressive pneumonia, development of a hyperinflammatory state and cytokine release syndrome (CRS) who was successfully treated with steroids and tocilizumab. CASE REPORT","PeriodicalId":75326,"journal":{"name":"Wits journal of clinical medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82498234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Potential Impact of SARS-CoV-2 Infection in HIV-positive Patients in South Africa 南非艾滋病毒阳性患者感染SARS-CoV-2的潜在影响
Pub Date : 2020-04-01 DOI: 10.18772/26180197.2020.v2nSIa3
C. Feldman
ABSTRACT Coronaviruses are important causes of infection in both humans and animals. While in the past they were considered to be relatively harmless respiratory pathogens, outbreaks of infection with severe acute respiratory syndrome (SARS), Middle East respiratory syndrome, and currently SARS-CoV-2, have confirmed how serious these pathogens can be in respiratory tract infections. Certain conditions and underlying comorbidities are known to be risk factors for SARS-CoV-2 infection, and for associated severe disease, including older age, underlying chronic cardiovascular and respiratory conditions and diabetes mellitus. There are a number of additional conditions and comorbidities that are suspected as being important risk factors, but for which hard evidence is currently lacking. This includes underlying human immunodeficiency virus infection, which represents the major focus of this current survey of the scientific literature.
冠状病毒是人类和动物感染的重要原因。虽然过去它们被认为是相对无害的呼吸道病原体,但严重急性呼吸道综合征(SARS)、中东呼吸综合征和目前的SARS- cov -2感染的爆发已经证实了这些病原体在呼吸道感染中的严重程度。已知某些情况和潜在的合并症是SARS-CoV-2感染以及相关严重疾病的危险因素,包括年龄较大、潜在的慢性心血管和呼吸系统疾病以及糖尿病。还有一些其他疾病和合并症被怀疑是重要的危险因素,但目前缺乏确凿的证据。这包括潜在的人类免疫缺陷病毒感染,这是当前科学文献调查的主要焦点。
{"title":"Potential Impact of SARS-CoV-2 Infection in HIV-positive Patients in South Africa","authors":"C. Feldman","doi":"10.18772/26180197.2020.v2nSIa3","DOIUrl":"https://doi.org/10.18772/26180197.2020.v2nSIa3","url":null,"abstract":"ABSTRACT Coronaviruses are important causes of infection in both humans and animals. While in the past they were considered to be relatively harmless respiratory pathogens, outbreaks of infection with severe acute respiratory syndrome (SARS), Middle East respiratory syndrome, and currently SARS-CoV-2, have confirmed how serious these pathogens can be in respiratory tract infections. Certain conditions and underlying comorbidities are known to be risk factors for SARS-CoV-2 infection, and for associated severe disease, including older age, underlying chronic cardiovascular and respiratory conditions and diabetes mellitus. There are a number of additional conditions and comorbidities that are suspected as being important risk factors, but for which hard evidence is currently lacking. This includes underlying human immunodeficiency virus infection, which represents the major focus of this current survey of the scientific literature.","PeriodicalId":75326,"journal":{"name":"Wits journal of clinical medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85267026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Social Dimensions of COVID-19 in South Africa: A Neglected Element of the Treatment Plan 2019冠状病毒病在南非的社会层面:治疗计划中被忽视的因素
Pub Date : 2020-04-01 DOI: 10.18772/26180197.2020.v2nSIa6
L. Baldwin-Ragaven
Notwithstanding moments of shared elation – Nelson Mandela’s triumphant release from prison 30 years ago, those halcyon weeks in 2010 when we were hosts to the Soccer World Cup, or more recently Siya Kolisi’s diverse team of players overcoming enormous odds to achieve a global rugby victory – the unity and transcendence of the rainbow nation largely have eluded us. While a pandemic is not the occasion to point fingers, it does expose the structural fault lines that undermine social cohesion. In “normal” times, these fissures are mostly tucked away safely in the recesses of our national collective consciousness. It is as if the virus, anthropomorphised, has pulled back the veil, baring the naked truth of our imperfect realities. There is no place to hide; and, to be totally honest, we are afraid.
尽管我们有过共同的喜悦时刻——30年前纳尔逊·曼德拉(Nelson Mandela)从监狱中大获全胜,2010年我们主办足球世界杯(World Cup)的那些平静的几周,以及最近西亚·科利西(Siya Kolisi)的多元化球员团队克服巨大的困难,在全球橄榄球比赛中取得胜利——但这个彩虹之国的团结和卓越在很大程度上与我们无缘。虽然大流行不是指责的机会,但它确实暴露了破坏社会凝聚力的结构性断层线。在“正常”时期,这些裂痕大多被安全地隐藏在我们国家集体意识的深处。就好像这种拟人化的病毒揭开了面纱,暴露了我们不完美现实的赤裸裸真相。没有地方可以躲藏;而且,说实话,我们很害怕。
{"title":"Social Dimensions of COVID-19 in South Africa: A Neglected Element of the Treatment Plan","authors":"L. Baldwin-Ragaven","doi":"10.18772/26180197.2020.v2nSIa6","DOIUrl":"https://doi.org/10.18772/26180197.2020.v2nSIa6","url":null,"abstract":"Notwithstanding moments of shared elation – Nelson Mandela’s triumphant release from prison 30 years ago, those halcyon weeks in 2010 when we were hosts to the Soccer World Cup, or more recently Siya Kolisi’s diverse team of players overcoming enormous odds to achieve a global rugby victory – the unity and transcendence of the rainbow nation largely have eluded us. While a pandemic is not the occasion to point fingers, it does expose the structural fault lines that undermine social cohesion. In “normal” times, these fissures are mostly tucked away safely in the recesses of our national collective consciousness. It is as if the virus, anthropomorphised, has pulled back the veil, baring the naked truth of our imperfect realities. There is no place to hide; and, to be totally honest, we are afraid.","PeriodicalId":75326,"journal":{"name":"Wits journal of clinical medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80664308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
期刊
Wits journal of clinical medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1